Northrim BanCorp, Inc. Raises Quarterly Cash Dividend 5.3% to $0.20 per Share
Aug 26, 2016 13:00 pm UTC| Business
ANCHORAGE, Alaska, Aug. 26, 2016 -- Northrim BanCorp, Inc. (NASDAQ:NRIM) today announced that its Board of Directors increased its regular quarterly cash dividend by $0.01, or 5.3%, to $0.20 per share. The dividend will...
Aug 26, 2016 13:00 pm UTC| Business
NEW YORK, Aug. 26, 2016 -- Extreme Reach, the enterprise cloud platform that powers the start-to-finish workflow for brand TV and Video ads, announced today a partnership with Samba TV, the leading provider of real-time...
Aug 26, 2016 13:00 pm UTC| Business
EL SEGUNDO, Calif., Aug. 26, 2016 -- Landmark Infrastructure Partners LP (Nasdaq:LMRK) has been invited to present at the 2016 Gateway Conference, which is being held on September 7-8, 2016 at the Four Seasons Hotel in...
MaxLinear, Inc. to Present at Upcoming Financial Conferences
Aug 26, 2016 12:30 pm UTC| Business
CARLSBAD, Calif., Aug. 26, 2016 -- MaxLinear, Inc. (NYSE:MXL), a leading provider of radio frequency (RF) and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and...
STARTEK to Present at the 5th Annual Liolios Gateway Conference on September 8, 2016
Aug 26, 2016 12:30 pm UTC| Business
GREENWOOD VILLAGE, Colo., Aug. 26, 2016 -- StarTek, Inc. ("STARTEK") (NYSE:SRT), a provider of business process outsourcing services, has been invited to present at the 2016 Liolios Gateway Conference being held...
PositiveID Completes Acquisition of Thermomedics and the Caregiver Non-Contact Thermometer
Aug 26, 2016 12:30 pm UTC| Business
DELRAY BEACH, Fla., Aug. 26, 2016 -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that it has completed its acquisition...
Aug 26, 2016 12:00 pm UTC| Business
NEW YORK, Aug. 26, 2016 -- TG Therapeutics, Inc.(NASDAQ:TGTX) today announced that theU.S. Food and Drug Administration(FDA) has granted orphan drug designation for TG-1101 (ublituximab) the Company’s novel,...